查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589338

椎间盘退化性疾病市场：按产品类型、治疗方法、最终用户划分 - 全球预测 2025-2030

Degenerative Disc Disease Market by Product Type (Devices, Drugs), Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine), End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年椎间盘退化性疾病市场估值为20.2亿美元，预计2024年将达到21.7亿美元，复合年增长率为7.73%，到2030年将达到34.1亿美元。

退化性疾病(DDD) 包括因椎间盘断裂而导致的病症，通常由老龄化引起，但也由损伤和遗传因素引起。这种疾病会导致严重的疼痛和行动问题。由于世界人口老化、久坐的生活方式和肥胖率上升，DDD 的发病率不断增加，医疗产业正在加大研发投资，以创新治疗方法和手术干预措施。应用范围延伸至整形外科诊所、医院及专科復健中心，最终用户为中重度DDD患者。市场开拓洞察表明，微创手术技术的持续发展，以及生技药品注射和再生医学等非手术干预措施，是关键的成长要素。用于诊断成像和客製化治疗计划的人工智慧的进步也推动了显着的成长。

主要市场统计
基准年[2023] 20.2亿美元
预测年份 [2024] 21.7亿美元
预测年份 [2030] 34.1亿美元
复合年增长率（%） 7.73%

再生医学研究，特别是干细胞疗法和软骨再生，是一个新兴的商机，因为它有望成为一种非侵入性替代医学。然而，高昂的治疗成本、核准新治疗方法的监管障碍以及欠发达地区缺乏早期疾病管理意识给市场成长带来了挑战。此外，儘管技术取得了进步，但新兴市场对此类先进治疗方法的采用仍然有限。利用这些机会的研究包括专注于成本削减策略、加强研究机构和医疗技术公司之间的合作以及加速创新。投资教育活动以提高人们对 DDD 早期检测和管理的认识，可以建立一个巨大的开拓市场。该市场竞争激烈，但前景广阔，在以患者为中心的治疗和先进生技药品方面具有巨大的创新空间。相关人员将个人化医疗、用于脊椎健康监测的可穿戴技术和用于患者资料分析的深度学习演算法方面的突破视为未来的重要开拓领域，以支持持续的市场扩张和患者成长，希望确保改善结果。

市场动态：揭示快速发展的退化性疾病市场的关键市场洞察

供需的动态交互作用正在改变退化性疾病市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 退化性疾病增加
    • 对非手术治疗方案的偏好日益增加
    • 物理治疗和止痛药物等保守治疗的可用性
  • 市场限制因素
    • 手术费用上升
  • 市场机会
    • 退化性疾病治疗的技术进展
    • 机器人技术在手术中的应用
  • 市场问题
    • 替代治疗的可用性

波特的五力：驾驭退化性疾病市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解退化性疾病市场的外部影响

外部宏观环境因素在塑造椎间盘退化性疾病市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解退化性疾病市场的竞争格局

椎间盘退化性疾病市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵：椎间盘退化性疾病市场供应商绩效评估

FPNV 定位矩阵是评估退化性疾病市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製退化性疾病市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对退化性疾病市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

它也回答重要问题，帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 退化性椎间盘疾病的发生率增加
      • 非手术治疗选择越来越受欢迎
      • 物理治疗和止痛药物等保守治疗的可用性
    • 抑制因素
      • 退化性疾病手术费用高
    • 机会
      • 退化性疾病治疗的技术进展
      • 机器人技术在手术中的应用
    • 任务
      • 替代治疗的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章椎间盘退化性疾病市场：依产品类型

  • 介绍
  • 装置
    • 颈椎
    • 腰椎
    • 脊椎融合手术
    • 胸椎
  • 药品
    • 乙酰胺酚
    • 肌肉鬆弛剂
    • NSAID
    • 口服类固醇

第七章椎间盘退化性疾病市场：依治疗分类

  • 介绍
  • 人工全人工椎间盘置换术
  • 颈椎
  • 腰椎
  • 脊椎融合手术
  • 胸椎

第八章椎间盘退化性疾病市场：依最终用户分类

  • 介绍
  • 诊所
  • 医院

第九章美洲退化性疾病市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太退化性疾病市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲退化性疾病市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AnGes MG, Inc.
  • B. Braun SE
  • Biopharm GmbH
  • Cerapedics Inc.
  • DePuy Synthes by Medical Device Business Services, Inc.
  • Globus Medical Inc.
  • Kolon TissueGene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Medtronic PLC
  • NLC Ventures Netherlands BV
  • Notogen, Inc.
  • Pfizer Inc.
  • Smith & Nephew PLC
  • Ulrich Medical USA Inc.
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-4659C8712D83

The Degenerative Disc Disease Market was valued at USD 2.02 billion in 2023, expected to reach USD 2.17 billion in 2024, and is projected to grow at a CAGR of 7.73%, to USD 3.41 billion by 2030.

Degenerative Disc Disease (DDD) encompasses a condition that arises from the wear-and-tear of intervertebral discs, commonly attributing to aging but also facilitated by injury and genetic factors. This condition can lead to severe pain and mobility issues. Necessitated by the growing incidence of DDD, driven by an aging global population, sedentary lifestyles, and rising obesity rates, the healthcare industry is increasingly investing in research and development to innovate therapeutic and surgical interventions. The application scope extends to orthopedic clinics, hospitals, and specialized rehabilitation centers with end-users being patients suffering from moderate to severe forms of DDD. Market insights reveal that continuous developments in minimally invasive surgical techniques, along with non-surgical interventions like biologic injections and regenerative medicines, are critical growth influencers. Advances in artificial intelligence for diagnostic imaging and tailored treatment plans also provide significant growth traction.

KEY MARKET STATISTICS
Base Year [2023] USD 2.02 billion
Estimated Year [2024] USD 2.17 billion
Forecast Year [2030] USD 3.41 billion
CAGR (%) 7.73%

Opportunities emerge in regenerative medicine research, particularly stem cell therapy and cartilage regeneration, as they present promising non-invasive alternatives. However, market growth is challenged by high treatment costs, regulatory hurdles in approving new treatments, and a lack of awareness about early-stage disease management in underdeveloped regions. Moreover, despite technological advancements, the penetration of such sophisticated treatments in emerging markets remains limited. Recommendations for capitalizing on these opportunities include focusing on cost reduction strategies and increasing collaboration between research institutions and medical technology firms to fast-track innovation. Investment in educational initiatives to raise awareness about early detection and management of DDD can establish large untapped markets. The nature of the market is highly competitive yet promising, with substantial room for innovation in patient-centric therapies and advanced biologics. Stakeholders are encouraged to prioritize breakthroughs in personalized medicine, wearable technology for spinal health monitoring, and deep learning algorithms for patient data analysis as pivotal areas for future developments, ensuring sustained market expansion and improved patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Degenerative Disc Disease Market

The Degenerative Disc Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising occurrences of degenerative disc disorders
    • Increasing preference for non-surgical treatment options
    • Availability of conservative therapies such as physical therapy, and pain relievers
  • Market Restraints
    • High cost of degenerative disc disease surgeries
  • Market Opportunities
    • Technological advancements in degenerative disc disease treatments
    • Introduction of robotic technology in surgical procedures
  • Market Challenges
    • Availability of alternative therapies

Porter's Five Forces: A Strategic Tool for Navigating the Degenerative Disc Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Degenerative Disc Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Degenerative Disc Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Degenerative Disc Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Degenerative Disc Disease Market

A detailed market share analysis in the Degenerative Disc Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Degenerative Disc Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Degenerative Disc Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Degenerative Disc Disease Market

A strategic analysis of the Degenerative Disc Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include AnGes MG, Inc., B. Braun SE, Biopharm GmbH, Cerapedics Inc., DePuy Synthes by Medical Device Business Services, Inc., Globus Medical Inc., Kolon TissueGene Inc., Lineage Cell Therapeutics, Inc., Medtronic PLC, NLC Ventures Netherlands B.V., Notogen, Inc., Pfizer Inc., Smith & Nephew PLC, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Degenerative Disc Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Devices and Drugs. The Devices is further studied across Cervical Spine, Lumbar Spine, Spinal Fusion, and Thoracic Spine. The Drugs is further studied across Acetaminophen, Muscle Relaxants, NSAIDs, and Oral Steroids.
  • Based on Treatment, market is studied across Artificial Disc Replacement, Cervical Spine, Lumbar Spine, Spinal Fusion, and Thoracic Spine.
  • Based on End-Users, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising occurrences of degenerative disc disorders
      • 5.1.1.2. Increasing preference for non-surgical treatment options
      • 5.1.1.3. Availability of conservative therapies such as physical therapy, and pain relievers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of degenerative disc disease surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in degenerative disc disease treatments
      • 5.1.3.2. Introduction of robotic technology in surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Degenerative Disc Disease Market, by Product Type

  • 6.1. Introduction
  • 6.2. Devices
    • 6.2.1. Cervical Spine
    • 6.2.2. Lumbar Spine
    • 6.2.3. Spinal Fusion
    • 6.2.4. Thoracic Spine
  • 6.3. Drugs
    • 6.3.1. Acetaminophen
    • 6.3.2. Muscle Relaxants
    • 6.3.3. NSAIDs
    • 6.3.4. Oral Steroids

7. Degenerative Disc Disease Market, by Treatment

  • 7.1. Introduction
  • 7.2. Artificial Disc Replacement
  • 7.3. Cervical Spine
  • 7.4. Lumbar Spine
  • 7.5. Spinal Fusion
  • 7.6. Thoracic Spine

8. Degenerative Disc Disease Market, by End-Users

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Degenerative Disc Disease Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Degenerative Disc Disease Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Degenerative Disc Disease Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AnGes MG, Inc.
  • 2. B. Braun SE
  • 3. Biopharm GmbH
  • 4. Cerapedics Inc.
  • 5. DePuy Synthes by Medical Device Business Services, Inc.
  • 6. Globus Medical Inc.
  • 7. Kolon TissueGene Inc.
  • 8. Lineage Cell Therapeutics, Inc.
  • 9. Medtronic PLC
  • 10. NLC Ventures Netherlands B.V.
  • 11. Notogen, Inc.
  • 12. Pfizer Inc.
  • 13. Smith & Nephew PLC
  • 14. Ulrich Medical USA Inc.
  • 15. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEGENERATIVE DISC DISEASE MARKET DYNAMICS
  • TABLE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ARTIFICIAL DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 238. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023